Alector, Inc. (ALEC) stock
ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.57+0.01 (+0.39%)
Close on Nov 18, 2026Market cap $286.96MP/E –Yield –
Alector revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Alector's revenue for the twelve months ending Jun 30, 2026 was $13.86M, down 82.9% year over year. For fiscal 2025 it was $21.05M, down 79.1% from the year before. The highest annual figure on record is $207.09M in fiscal 2021.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.05M | -79.1% |
| FY2024 | Dec 31, 2024 | $100.56M | +3.6% |
| FY2023 | Dec 31, 2023 | $97.10M | -27.3% |
| FY2022 | Dec 31, 2022 | $133.60M | -35.5% |
| FY2021 | Dec 31, 2021 | $207.09M | +881.5% |
| FY2020 | Dec 31, 2020 | $21.10M | -0.6% |
| FY2019 | Dec 31, 2019 | $21.22M | -23.3% |
| FY2018 | Dec 31, 2018 | $27.68M | +641.0% |
| FY2017 | Dec 31, 2017 | $3.74M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.32M | -57.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.05M | -71.5% |
| Q4 FY2025 | Dec 31, 2025 | $6.24M | -88.5% |
| Q3 FY2025 | Sep 30, 2025 | $3.26M | -78.8% |
| Q2 FY2025 | Jun 30, 2025 | $7.87M | -47.8% |
| Q1 FY2025 | Mar 31, 2025 | $3.67M | -76.9% |
| Q4 FY2024 | Dec 31, 2024 | $54.24M | +256.2% |
| Q3 FY2024 | Sep 30, 2024 | $15.34M | +68.4% |
| Q2 FY2024 | Jun 30, 2024 | $15.08M | -73.2% |
| Q1 FY2024 | Mar 31, 2024 | $15.90M | -3.9% |
| Q4 FY2023 | Dec 31, 2023 | $15.23M | +5.6% |
| Q3 FY2023 | Sep 30, 2023 | $9.11M | -38.7% |
| Q2 FY2023 | Jun 30, 2023 | $56.21M | -29.6% |
| Q1 FY2023 | Mar 31, 2023 | $16.55M | -32.4% |
| Q4 FY2022 | Dec 31, 2022 | $14.42M | +3.1% |
| Q3 FY2022 | Sep 30, 2022 | $14.85M | -91.9% |
| Q2 FY2022 | Jun 30, 2022 | $79.85M | +1115.8% |
| Q1 FY2022 | Mar 31, 2022 | $24.47M | +495.5% |
| Q4 FY2021 | Dec 31, 2021 | $13.99M | +188.4% |
| Q3 FY2021 | Sep 30, 2021 | $182.41M | +2989.7% |
| Q2 FY2021 | Jun 30, 2021 | $6.57M | +107.2% |
| Q1 FY2021 | Mar 31, 2021 | $4.11M | -42.7% |
| Q4 FY2020 | Dec 31, 2020 | $4.85M | -19.1% |
| Q3 FY2020 | Sep 30, 2020 | $5.90M | +119.0% |
| Q2 FY2020 | Jun 30, 2020 | $3.17M | -54.2% |
| Q1 FY2020 | Mar 31, 2020 | $7.17M | +27.9% |
| Q4 FY2019 | Dec 31, 2019 | $6.00M | -34.4% |
| Q3 FY2019 | Sep 30, 2019 | $2.70M | -58.5% |
| Q2 FY2019 | Jun 30, 2019 | $6.92M | -2.7% |
| Q1 FY2019 | Mar 31, 2019 | $5.61M | +13.9% |
| Q4 FY2018 | Dec 31, 2018 | $9.15M | – |
| Q3 FY2018 | Sep 30, 2018 | $6.50M | – |
| Q2 FY2018 | Jun 30, 2018 | $7.11M | – |
| Q1 FY2018 | Mar 31, 2018 | $4.92M | – |
See a number that looks wrong?